Joseph K. Belanoff
2021
In 2021, Joseph K. Belanoff earned a total compensation of $11M as Chief Executive Officer and President at Corcept Therapeutics, a 91% increase compared to previous year.
Compensation breakdown
| Bonus | $850,000 |
|---|---|
| Option Awards | $9,290,888 |
| Salary | $843,750 |
| Total | $10,984,638 |
Belanoff received $9.3M in option awards, accounting for 85% of the total pay in 2021.
Belanoff also received $850K in bonus and $843.8K in salary.
Rankings
In 2021, Joseph K. Belanoff's compensation ranked 896th out of 12,415 executives tracked by ExecPay. In other words, Belanoff earned more than 92.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 896 out of 12,415 | 93rd |
Division Manufacturing | 299 out of 5,505 | 95th |
Major group Chemicals And Allied Products | 100 out of 2,375 | 96th |
Industry group Drugs | 84 out of 2,096 | 96th |
Industry Pharmaceutical Preparations | 55 out of 1,546 | 96th |
Source: SEC filing on April 25, 2022.
Belanoff's colleagues
We found four more compensation records of executives who worked with Joseph K. Belanoff at Corcept Therapeutics in 2021.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019